Global Onychomycosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Onychomycosis Treatment Market Overview

• 1.1 Product Overview and Scope of Onychomycosis Treatment
• 1.2 Classification of Onychomycosis Treatment by Types
  • 1.2.1 Global Onychomycosis Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Onychomycosis Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Medication
  • 1.2.4 Lasers
  • 1.2.5 Photodynamic Therapy
• 1.3 Global Onychomycosis Treatment Market by Application
  • 1.3.1 Global Onychomycosis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Dermatology Clinics
  • 1.3.4 Retail Pharmacies
  • 1.3.5 Online Pharmacies
• 1.4 Global Onychomycosis Treatment Market by Regions
  • 1.4.1 Global Onychomycosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Onychomycosis Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Onychomycosis Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Onychomycosis Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Onychomycosis Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Onychomycosis Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Onychomycosis Treatment (2014-2024)

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Onychomycosis Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Novartis
  • 2.2.1 Business Overview
  • 2.2.2 Onychomycosis Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Novartis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Johnson & Johnson
  • 2.3.1 Business Overview
  • 2.3.2 Onychomycosis Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Johnson & Johnson Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bausch Health
  • 2.4.1 Business Overview
  • 2.4.2 Onychomycosis Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bausch Health Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Bayer
  • 2.5.1 Business Overview
  • 2.5.2 Onychomycosis Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Bayer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Lumenis
  • 2.6.1 Business Overview
  • 2.6.2 Onychomycosis Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Lumenis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Galderma
  • 2.7.1 Business Overview
  • 2.7.2 Onychomycosis Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Galderma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Moberg Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Onychomycosis Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Moberg Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Cipla
  • 2.9.1 Business Overview
  • 2.9.2 Onychomycosis Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Cipla Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Biofrontera
  • 2.10.1 Business Overview
  • 2.10.2 Onychomycosis Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Biofrontera Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Leo Pharma
  • 2.11.1 Business Overview
  • 2.11.2 Onychomycosis Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Leo Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Dr. Reddy's Laboratories
  • 2.12.1 Business Overview
  • 2.12.2 Onychomycosis Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Medimetriks Pharmaceuticals
  • 2.13.1 Business Overview
  • 2.13.2 Onychomycosis Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Onychomycosis Treatment Market Competition, by Players

• 3.1 Global Onychomycosis Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Onychomycosis Treatment Players Market Share
  • 3.2.2 Top 10 Onychomycosis Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Onychomycosis Treatment Market Size by Regions

• 4.1 Global Onychomycosis Treatment Revenue and Market Share by Regions
• 4.2 North America Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

5 North America Onychomycosis Treatment Revenue by Countries

• 5.1 North America Onychomycosis Treatment Revenue by Countries (2014-2019)
• 5.2 USA Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

6 Europe Onychomycosis Treatment Revenue by Countries

• 6.1 Europe Onychomycosis Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Onychomycosis Treatment Revenue by Countries

• 7.1 Asia-Pacific Onychomycosis Treatment Revenue by Countries (2014-2019)
• 7.2 China Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

8 South America Onychomycosis Treatment Revenue by Countries

• 8.1 South America Onychomycosis Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Onychomycosis Treatment by Countries

• 9.1 Middle East and Africa Onychomycosis Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Onychomycosis Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Onychomycosis Treatment Revenue and Growth Rate (2014-2019)

10 Global Onychomycosis Treatment Market Segment by Type

• 10.1 Global Onychomycosis Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Onychomycosis Treatment Market Forecast by Type (2019-2024)
• 10.3 Medication Revenue Growth Rate (2014-2024)
• 10.4 Lasers Revenue Growth Rate (2014-2024)
• 10.5 Photodynamic Therapy Revenue Growth Rate (2014-2024)

11 Global Onychomycosis Treatment Market Segment by Application

• 11.1 Global Onychomycosis Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Onychomycosis Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Dermatology Clinics Revenue Growth (2014-2019)
• 11.5 Retail Pharmacies Revenue Growth (2014-2019)
• 11.6 Online Pharmacies Revenue Growth (2014-2019)

12 Global Onychomycosis Treatment Market Size Forecast (2019-2024)

• 12.1 Global Onychomycosis Treatment Market Size Forecast (2019-2024)
• 12.2 Global Onychomycosis Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Onychomycosis Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Onychomycosis Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Onychomycosis Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Onychomycosis Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Onychomycosis Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology